Demonstrating vaccine effectiveness during a waning epidemic: A WHO/NIH meeting report on approaches to development and licensure of Zika vaccine candidates

Since its peak in early 2016, the incidence of Zika virus (ZIKV) cases has declined to such low levels that Phase 3 field efficacy trials may be infeasible. While great progress was made to rapidly advance several vaccine candidates into Phase 1 and 2 clinical trials, in the absence of sustained vir...

Descripción completa

Detalles Bibliográficos
Autores principales: Vannice, Kirsten S., Cassetti, M. Cristina, Eisinger, Robert W., Hombach, Joachim, Knezevic, Ivana, Marston, Hilary D., Wilder-Smith, Annelies, Cavaleri, Marco, Krause, Philip R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357529/
https://www.ncbi.nlm.nih.gov/pubmed/30639461
http://dx.doi.org/10.1016/j.vaccine.2018.12.040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357529/
https://www.ncbi.nlm.nih.gov/pubmed/30639461
http://dx.doi.org/10.1016/j.vaccine.2018.12.040

Ejemplares similares